Intelligent Medicine Acquisition Corp.

Intelligent Medicine Acquisition Corp. (Nasdaq: IQMD) is a blank-check company formed to pursue business combinations in the healthcare and life sciences sector, with a mandate centered on intelligent and technology-enabled medicine. The vehicle went public in 2021 during the peak of SPAC market activity and targeted opportunities at the intersection of digital health and life sciences. On May 12, 2023, the company filed a Form 15-12G with the SEC, initiating the termination of its registration under Section 12(g) of the Securities Exchange Act and marking a formal change in the vehicle's reporting status. Sign up for SpacDesk to access complete filing history, sponsor details, and deal timelines for IQMD and hundreds of other SPACs.